Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

Follistatin 315

Activin-Binding Protein, FSH-Suppressing Protein, FST-315, FS-315

Quick Stats
Studies 14
Trials 93
Recruiting NA INTERVENTIONAL NCT07021079

Muscle Vibration as a Countermeasure Against Hypoactivity-induced

View on ClinicalTrials.gov Updated Dec 15, 2025

Brief Summary

Muscle deconditioning, characterized by a loss of muscle mass and strength, is a frequent consequence of prolonged lower limb unloading. Beyond muscle mass loss, reduced neural drive contributes significantly to strength decline, highlighting the need for interventions targeting neuromuscular function during immobilization. Focal muscle vibration (FMV) has shown promise in modulating neuromuscular excitability by activating muscle spindle afferents and inducing cortical adaptations. Chronic use of FMV has been associated with significant strength gains and improved neural command. This makes FMV an effective rehabilitation tool. Its simplicity and non-invasiveness further make it a practical countermeasure.

Detailed Description

This study hypothesizes that a 10-day FMV protocol can induce neural adaptations to limit strength loss during unilateral lower limb suspension, offering a novel strategy against neuromuscular function decline.

Interventions

Name: Focal muscle vibration
Type: DEVICE
Description: focal muscle vibration sessions, using small and portable vibrator devices.
Name: NO Focal muscle vibration
Type: DEVICE
Description: The control group will not receive any intervention.

Primary Outcomes

Measure: Isometric force measurement
TimeFrame: Day 1, 7, 14, 28, 33
Description: Maximal isometric force (% decrease) in knee extension of the immobilized leg will be evaluated

Trial Information

NCT ID

NCT07021079

Status

Recruiting

Study Type

INTERVENTIONAL

Phases

NA

Sponsor

Centre Hospitalier Universitaire de Saint Etienne

Last Updated

December 15, 2025

Related Peptides